Cafepharma Today

December 12 2024 - Industry M&A volume declined 8% this year compared to '23
Industry M&A volume declined 8% this year compared to '23
Pfizer's Ibrance improves survival in new breast cancer indication
Lynparza boosts long-term survival in early breast cancer
Trump says "big discussion" over childhood vaccine programs is coming
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Danish court protects patents on Pfizer's Lipitor from challenge by Ranbaxy Laboratories
Yahoo/AP
Friday, August 29, 2008 - 10:05am
tags:
Maker of Eye Drug Frowns on Study
Red Orbit
Friday, August 29, 2008 - 9:58am
tags:
GlaxoSmithKline drug ad sparks a debate
Trading Markets
Friday, August 29, 2008 - 9:55am
tags:
Sick of ‘me-too’ pharma, Upsher-Smith shops for biotech
Bizjournals.com
Friday, August 29, 2008 - 9:53am
tags:
Antipsychotic drugs double stroke risk: study
Reuters
Friday, August 29, 2008 - 8:02am
tags:
Making a Name for Drugs Without Using Their Names
WSJ Online
Friday, August 29, 2008 - 8:01am
tags:
Pharma Patents And Why Indonesia Is Hoarding Bird Flu Samples
Techdirt
Friday, August 29, 2008 - 7:58am
tags:
SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial
Seeking Alpha
Friday, August 29, 2008 - 7:49am
tags:
Novartis halts development of antibiotic drug To take $235 million charge to third-quarter results
Marketwatch
Friday, August 29, 2008 - 6:34am
tags:
Judge rules J&J drug patent is invalid
Star Ledger, NJ
Friday, August 29, 2008 - 6:31am
tags:
Stent Probe Undermines J&J, Abbott, Boston Scientific Target
Bloomberg
Friday, August 29, 2008 - 6:29am
tags:
A Big Upgrade for Eli Lilly
Motley Fool
Thursday, August 28, 2008 - 5:08pm
tags:
Schering and Pfizer Aren't Horsing Around
Motley Fool
Thursday, August 28, 2008 - 5:07pm
tags:
Me-Too Drugs: Are They Worth It?
Motley Fool
Thursday, August 28, 2008 - 5:06pm
tags:
Affymax, Takeda narrow Hematide focus
Bizjournals.com
Thursday, August 28, 2008 - 5:05pm
tags:
Buy! Sell! Analysts Duke It Out Over Amylin
WSJ Online
Thursday, August 28, 2008 - 5:02pm
tags:
The Vioxx ‘V’ Squad: Reps From Another Universe
Pharmalot
Thursday, August 28, 2008 - 5:00pm
tags:
Amylin Pharmaceuticals shares recover some sharp losses following new Byetta deaths
Yahoo/AP
Thursday, August 28, 2008 - 12:53pm
tags:
Valeant and GlaxoSmithKline enter worldwide collaboration agreement for retigabine
RTT News
Thursday, August 28, 2008 - 11:11am
tags:
Merck's Charm Offensive
CNBC
Thursday, August 28, 2008 - 11:10am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)
Drug Channels
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)
Drug Channels
Bad Bar Graphs
In the Pipeline
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating (rerun)
Drug Channels
Infant RSV Vaccination Trouble
In the Pipeline
The BioSecure Act Falters?
In the Pipeline
Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble? (rerun)
Drug Channels
Computational Care
In the Pipeline
The Rings Less Traveled
In the Pipeline

Latest Jobs

Virtual Biopharma Sales Specialist
Raleigh, North Carolina, 27601
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement - Santa Rosa, CA
Santa Rosa, California,
Otsuka
Portfolio Sales Specialist - North Dakota / South Dakota / Nebraska
Lincoln, Nebraska, 68511
ICU Medical
Bilingual Business Development Representative
Kennedy Space Center, Florida
Complete Care
Business Development Manager, Facial - Chevy Chase, MD
Chevy Chase, Maryland, 20815
AbbVie
Virtual Biopharma Sales Specialist
Dallas, Texas, 75215
Syneos Health/ inVentiv Health Commercial LLC
Regional Director, Central Baltimore, Maryland, United States
Baltimore, Maryland, 21276
TBWA\Chiat\Day
Account Executive
San Antonio, Texas, 78208
Elara Caring
Nobel Biocare Regional Manager - Mid Atlantic
Washington, District of Columbia, 20022
enVista
Senior Manager, Professional Affairs (Northeast)
Jersey City, New Jersey, 07390
Bausch + Lomb
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information